LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Cash from Financing Activities (2015 - 2026)

LivaNova's (LIVN) quarterly Cash from Financing Activities came in at -$56.4 million in Q2 2026, up 72.99% year-over-year from -$32.6 million in Q2 2025, and up 40.11% quarter-over-quarter from -$94.2 million in Q1 2026.

Analysis

LivaNova (LIVN) Cash from Financing Activities (2015 - 2026) Analysis & Trends

LivaNova has disclosed Cash from Financing Activities across 12 years of filings, most recently posting -$56.4 million for Q2 2026.

  • In Q2 2026, Cash from Financing Activities rose 72.99% year-over-year to -$56.4 million; the TTM figure through Jun 2026 stood at -$223.0 million (down 1.28% YoY), while the FY2025 annual figure was -$285.7 million, down 1639.86% from the prior year.
  • Cash from Financing Activities came in at -$56.4 million for Q2 2026 at LivaNova, up from -$94.2 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $214.9 million in Q1 2022 to a low of -$209.0 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is -$6.5 million, with a median of -$4.7 million recorded in 2023.
  • Year-over-year, Cash from Financing Activities soared 2680.18% in 2022 and sank 2031.76% in 2026.
  • Over 5 years, Cash from Financing Activities stood at -$1.7 million in 2022, then plunged by 202.84% to -$5.0 million in 2023, then surged by 31.37% to -$3.4 million in 2024, then tumbled by 1725.9% to -$62.9 million in 2025, then rose by 10.23% to -$56.4 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$56.4 million in Q2 2026, -$94.2 million in Q1 2026, and -$62.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -300,000.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -607.30 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -213.50 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn -56.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -56.45 Mn
Mar 31, 2026 -94.25 Mn
Dec 31, 2025 -62.88 Mn
Sep 30, 2025 -9.37 Mn
Jun 30, 2025 -208.98 Mn
Mar 31, 2025 -4.42 Mn
Dec 31, 2024 -3.44 Mn
Sep 30, 2024 -3.28 Mn
Jun 30, 2024 -11.87 Mn
Mar 31, 2024 37.15 Mn
Dec 31, 2023 -5.02 Mn
Sep 30, 2023 -4.28 Mn
Jun 30, 2023 36.01 Mn
Mar 31, 2023 -5.24 Mn
Dec 31, 2022 -1.66 Mn
Sep 30, 2022 73.23 Mn
Jun 30, 2022 -6.32 Mn
Mar 31, 2022 214.88 Mn
Dec 31, 2021 -3.30 Mn
Sep 30, 2021 -164.10 Mn